We then used immunohistochemical staining to examine the distribution of IFN-α/β-induced FGFR1 within the tumors and found that levels of FGFR1 were increased at the cell membrane and in the cytoplasm of HCC cells (Figure 1E). The gene discussed is IFNA17; the disease is hepatocellular carcinoma.